Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    Open Studies | "Escherichia coli Infections"
Show Display Options
Rank Status Study
1 Recruiting Epidemiology of ST131 in Besançon University Hospital
Condition: Escherichia Coli Infections
Intervention:
2 Recruiting Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia Coli
Conditions: Infection Due to Escherichia Coli;   Acute Pyelonephritis
Interventions: Drug: Sitafloxacin;   Drug: Ertapenem
3 Recruiting Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients
Conditions: Anti-Infective Agents, Urinary;   Escherichia Coli Infections;   Klebsiella Infections;   Kidney Transplantation;   Urinary Tract Infections
Interventions: Drug: Sitafloxacin;   Drug: Ertapenem
4 Recruiting Safety of Sublingual dmLT for ETEC
Condition: Gastroenteritis Escherichia Coli
Intervention: Biological: Recombinant Double Mutant Heat-Labile Toxin LT(R192G/L211A) (dmLT) Oral entertoxigenic Escherichia coli (ETEC) Vaccine
5 Recruiting Phase 1 Study of dmLT ID Vaccination in Healthy Adults
Condition: Gastroenteritis Escherichia Coli
Interventions: Other: Placebo;   Biological: Recombinant Double Mutant Heat-Labile Toxin LT(R192G/L211A) (dmLT) Oral entertoxigenic Escherichia coli (ETEC) Vaccine

Study has passed its completion date and status has not been verified in more than two years.